49656-06-6

Upstream product

• 119-52-8 4,4'-dimethoxybenzoin 
• 49656-08-8 4,5-bis(4-methoxyphenyl)-4-oxazolin-2-one 

Downstream Products

• 113853-20-6 2-[[4,5-Bis-(4-methoxy-phenyl)-oxazol-2-yl]-(2-hydroxy-ethyl)-amino]-ethanol 
• 735266-96-3 4,5-Bis(4-methoxyphenyl)-2-(methylthio)-1,3-oxazole 
• 951744-64-2 4-(4,5-bis(4-methoxyphenyl)oxazol-2-yl)piperazine 
• 1224948-76-8 4-(4,5-bis(4-methoxyphenyl)oxazol-2-yl)cyclohexan-cis-1,4-diol 
• 1224948-75-7 4-(4,5-bis(4-methoxyphenyl)oxazol-2-yl)cyclohexan-trans-1,4-diol 
• 1224948-74-6 4-(4,5-bis(4-methoxyphenyl)oxazol-2-yl)-4-hydroxycyclohexan-1-one 
• 1224950-12-2 8-(4,5-bis(4-methoxyphenyl)oxazol-2-yl)-1,4-dioxaspiro[4.5]decan-8-ol 
• 113853-19-3 4,5-Bis-(4-methoxy-phenyl)-2-pyrrolidin-1-yl-oxazole 

Relevant academic research and scientific papers

UREIDE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES

This invention relates to a pharmaceutical comprising, as an active ingredient, a ureide derivative represented by formula: or a pharmaceutically acceptable salt thereof. The ureide derivative or a pharmaceutically acceptable salt thereof according to the present invention is useful for relieving pain and treating or preventing neuropathic pain.

OXAZOLE DERIVATIVES AS INHIBITORS OF CYCLOOXYGENASE

A compound of the formula (I): wherein R1 is cycloalkyl, etc; R2 is (lower)alkoxy, etc; R3 is (lower)alkylene, etc; R4 is (lower)alkylene, etc; R5 is hydroxy, etc; X is "0", "S", "SO", or "S02"; Y is "CH" or "N"; n is 0 or 1; or pharmaceutically acceptable salts thereof, which are useful as a medicament

Inhibitor of cox

A compound of the formula (I): wherein R1 is cycloalkyl, etc; R2 is (lower)alkoxy, etc; R3 is (lower)alkylene, etc; R4 is (lower)alkylene, etc; R5 is hydroxy, etc; X is “O”, “S”, “SO”, or “SO2”; Y is “CH” or “N”; n is 0 or 1; or pharmaceutically acceptable salts thereof, which are useful as a medicament.